BRUCE J DEZUBE, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA
License number
Massachusetts 54022
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
330 Brookline Ave, Boston, MA 02215
109 Meadowbrook Rd, Newton, MA 02459
109 Meadowbrook Rd, Newton, MA 02459
Phone
(617) 632-9258
Professional information
Dr. Bruce J Dezube, Boston MA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Beth Israel Deaconess ONC/HEM
330 Brookline Ave, Boston 02215
(617) 667-1004 (Phone)
330 Brookline Ave, Boston 02215
(617) 667-1004 (Phone)
Certifications:
Hematology, 1988, Internal Medicine, 1986, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Beth Israel Deaconess ONC/HEM
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Tufts University School Of Medicine
Graduated: 1983
New England Med Center
Graduated: 1984
Graduated: 1986
Beth Israel Deaconess Hospital
Graduated: 1989
Tufts University School Of Medicine
Graduated: 1983
New England Med Center
Graduated: 1984
Graduated: 1986
Beth Israel Deaconess Hospital
Graduated: 1989
Associate Professor Of Medicine At Beth Israel Deaconess Medical Center
Position:
Associate Professor of Medicine at Beth Israel Deaconess Medical Center
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Beth Israel Deaconess Medical Center
-
Associate Professor of Medicine
Bruce Jeffrey Dezube, Boston MA
Specialties:
Internal Medicine, Hematology, Medical Oncology, Infectious Disease, Gynecology, Hematology
Work:
Beth Israel Care Group
330 Brookline Ave, Boston, MA 02215
330 Brookline Ave, Boston, MA 02215
Education:
Tufts University (1983)
Bruce Dezube
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Administration Of Nedd8-Activating Enzyme Inhibitor
US Patent:
2012011, May 10, 2012
Filed:
Nov 3, 2011
Appl. No.:
13/288146
Inventors:
Bruce J. Dezube - Newton MA, US
Lilli M. Petruzzelli - Lexington MA, US
Lilli M. Petruzzelli - Lexington MA, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/519, A61P 35/00
US Classification:
5142651
Abstract:
Disclosed are methods for the treatment of patients with diseases, disorders or conditions responsive to the inhibition of NAE (Nedd8-activating enzyme), e.g., cancer. The methods comprise administering a clinically effective amount of the NAE-inhibitor ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate (MLN4924) according to an intermittent dosing regimen in which there is a rest period of at least two days between each administration.
Methods For Treating Viral Infections
US Patent:
5641773, Jun 24, 1997
Filed:
Nov 30, 1993
Appl. No.:
8/159509
Inventors:
Arthur P. Pardee - Brookline MA
Debajit K. Biswas - Newton MA
Bruce J. Dezube - Newton Centre MA
Debajit K. Biswas - Newton MA
Bruce J. Dezube - Newton Centre MA
Assignee:
Dana-Farber Cancer Institute - Boston MA
International Classification:
A61K 3155
US Classification:
514221
Abstract:
The present invention includes, inter alia, methods of treating cells infected with a virus capable of causing an immunodeficiency disease and related pharmaceutical compositions.